Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients

T

Tepecik Training and Research Hospital

Status

Unknown

Conditions

COVID-19

Treatments

Diagnostic Test: CT-Scan

Study type

Observational

Funder types

Other

Identifiers

NCT04424849
2020/5-4

Details and patient eligibility

About

The most common thorax Computed tomography (CT) findings are multifocal ground-glass opacities and peripheral consolidation in patients with COVID-19. Septal thickening, bronchiectasis, pleural thickening, and subpleural involvement may also be observed. Although these findings are not specific to COVID-19, the severity of pulmonary involvement is expected to be correlated with thorax CT findings.

Full description

Thorax computed tomography severity score defined by Yang et al. can be used to evaluate the severity of pulmonary involvement in COVID-19 patients. We aimed to investigate whether the initial thorax computed tomography severity score can predict mechanical ventilation requirement and mortality in COVID-19 patients.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • COVID-19 confirmed by positive RT-PCR and/or antibody testing
  • CT scan at intensive care unit admission

Exclusion criteria

  • Loss of CT data
  • Chronic lung disease findings by CT that may lead to misinterpretation
  • RT-PCR results unavailable or negative
  • Terminal cancer

Trial design

40 participants in 1 patient group

COVID-19 patients
Description:
Patient tested positive for COVID-19 who had a CT scan
Treatment:
Diagnostic Test: CT-Scan

Trial contacts and locations

1

Loading...

Central trial contact

PATRICIA GALVEZ

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems